xmlns:atom="http://www.w3.org/2005/Atom"
13. In Schedule 3(1) (applications for licences under Part 3), in paragraph 3(3)(d), after sub-paragraph (i) insert—
“(ia)EAMS medicinal products,”.
Relevant amendments have been made by S.I. 2019/775.